Cargando…

Pseudoginsenoside F11, a Novel Partial PPARγ Agonist, Promotes Adiponectin Oligomerization and Secretion in 3T3-L1 Adipocytes

PPARγ is a nuclear hormone receptor that functions as a master regulator of adipocyte differentiation and development. Full PPARγ agonists, such as the thiazolidinediones (TZDs), have been widely used to treat type 2 diabetes. However, they are characterized by undesirable side effects due to their...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Guoyu, Yi, Junyang, Liu, Ling, Wang, Pengcheng, Zhang, Zhijie, Li, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880755/ https://www.ncbi.nlm.nih.gov/pubmed/24454336 http://dx.doi.org/10.1155/2013/701017

Ejemplares similares

Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist
por: Goto, Tsuyoshi, et al.
Publicado: (2011)

Regulation of Serum Response Factor and Adiponectin by PPARγ Agonist Docosahexaenoic Acid
por: Johnson, Clayton, et al.
Publicado: (2011)

The Eicosapentaenoic Acid Metabolite 15-Deoxy-δ(12,14)-Prostaglandin J(3) Increases Adiponectin Secretion by Adipocytes Partly via a PPARγ-Dependent Mechanism
por: Lefils-Lacourtablaise, Jennifer, et al.
Publicado: (2013)

PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer
por: Ballav, Sangeeta, et al.
Publicado: (2022)

Valerenic Acid Promotes Adipocyte Differentiation, Adiponectin Production, and Glucose Uptake via Its PPARγ Ligand Activity
por: Takahashi, Jun, et al.
Publicado: (2022)

Cyclodextrin-Mediated Cholesterol Depletion Induces Adiponectin Secretion in 3T3-L1 Adipocytes
por: Chiang, Yu-Ting, et al.
Publicado: (2023)

Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
por: Ayza, Muluken Altaye, et al.
Publicado: (2020)

Synthesis and biological evaluation of dihydropyrano-[2,3-c]pyrazoles as a new class of PPARγ partial agonists
por: Qvortrup, Katrine, et al.
Publicado: (2017)

Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers
por: Loft, Anne, et al.
Publicado: (2015)

Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats
por: Afzal, Sheryar, et al.
Publicado: (2021)

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015)

DHA increases adiponectin expression more effectively than EPA at relative low concentrations by regulating PPARγ and its phosphorylation at Ser273 in 3T3-L1 adipocytes
por: Song, Jia, et al.
Publicado: (2017)

γ-tocotrienol attenuates TNF-α-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes
por: MATSUNAGA, TETSURO, et al.
Publicado: (2012)

Neuroprotective Effect of Pseudoginsenoside-F11 on a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine
por: Wang, Jian Yu, et al.
Publicado: (2013)

Terahertz Spectroscopy for Accurate Identification of Panax quinquefolium Basing on Nonconjugated 24(R)-Pseudoginsenoside F(11)
por: Kou, Tianyi, et al.
Publicado: (2021)

Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γ Agonist against MPTP
por: Swanson, Christine R., et al.
Publicado: (2013)

Structural and Dynamic Elucidation of a Non-acid PPARγ Partial Agonist: SR1988
por: Frkic, Rebecca L., et al.
Publicado: (2018)

Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists
por: Liberato, Marcelo Vizoná, et al.
Publicado: (2012)

PPARγ Agonists: Blood Pressure and Edema
por: Blazer-Yost, Bonnie L.
Publicado: (2010)

PPARγ Agonists: Emergent Therapy in Endometriosis
por: Vallée, Alexandre, et al.
Publicado: (2021)

Shockwaves Suppress Adipocyte Differentiation via Decrease in PPARγ
por: Cho, Wonkyoung, et al.
Publicado: (2020)

The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo
por: Wang, Hongbo, et al.
Publicado: (2014)

Novel Podophyllotoxin Derivatives as Partial PPARγ Agonists and their Effects on Insulin Resistance and Type 2 Diabetes
por: Zhang, Xiangming, et al.
Publicado: (2016)

Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes
por: Yasmin, Sabina, et al.
Publicado: (2017)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

PPARγ Agonists: Potential as Therapeutics for Neovascular Retinopathies
por: Pershadsingh, Harrihar A., et al.
Publicado: (2008)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
por: Tsukahara, Tamotsu
Publicado: (2012)

PPARγ Agonist Beyond Glucose Lowering Effect
por: Sugawara, Akira, et al.
Publicado: (2011)

Relaxation of human pulmonary arteries by PPARγ agonists
por: Kozłowska, Hanna, et al.
Publicado: (2013)

Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
por: Ellis, Hayley Patricia, et al.
Publicado: (2014)

PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
por: Harnchoowong, Sarawin, et al.
Publicado: (2017)

PPARγ and Its Agonists in Chronic Kidney Disease
por: Ma, Yuhua, et al.
Publicado: (2020)

Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro
por: Nicoll, Jim, et al.
Publicado: (2013)

Adipocytes protect fibroblasts from radiation-induced damage by adiponectin secretion
por: Kosmacek, Elizabeth A., et al.
Publicado: (2020)

Ubiquitin Ligase NEDD4 Regulates PPARγ Stability and Adipocyte Differentiation in 3T3-L1 Cells
por: Li, Jing Jing, et al.
Publicado: (2016)

Antiadipogenesis of Oroxylum indicum (L.) Kurz Extract via PPARγ2 in 3T3-L1 Adipocytes
por: Hengpratom, Tanaporn, et al.
Publicado: (2020)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

Regulation of Chemokine and Chemokine Receptor Expression by PPARγ in Adipocytes and Macrophages
por: Nguyen, M. T. Audrey, et al.
Publicado: (2012)

Identification of Regulatory Elements That Control PPARγ Expression in Adipocyte Progenitors
por: Chou, Wen-Ling, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lktta5jliitiftch47cb0ao9u6